drugset / Trial / NCT02134340
A Safety and Biodistribution Study of [I-124]-CPD-1028 Injection in Solid Tumours
NaSingle-groupOpen-labelDiagnostic
Summary
The purpose of the study is to evaluate the safety and biodistribution of \[I-124\]-CPD-1028 Injection in cancer patients with solid tumours.
Timeline
- Start
- 2014-06
- Primary completion
- 2016-06
- Completion
- 2016-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CPD-1061 | Unknown | 0.4 mg/kg | Intravenous |
| Subject | CPD-1061 | Unknown | 1.4 mg/kg | Intravenous |
| Subject | CPD-1061 | Unknown | 6 mg/kg | Intravenous |